NasdaqGS:PGNYHealthcare
Progyny (PGNY) Could Be 6% Overvalued As Shares Near Analyst Fair Value
Progyny (PGNY) is back in focus for investors after a recent move in its share price, with the stock up about 19% over the past month and roughly 77% over the past 3 months.
See our latest analysis for Progyny.
Those recent gains sit alongside a 21.8% year to date share price return and a 33.6% total shareholder return over the past year, while the 3 year and 5 year total shareholder returns remain weak. This suggests recent momentum in Progyny may reflect a reassessment of its growth...